Wegovy Pill Approval: Revolutionizing Weight Loss & Food Industry

The Food and Drug Administration has approved Novo Nordisks Wegovy pill, a GLP-one weight-loss drug that curbs appetite and is set to hit shelves in January. This pill is cheaper than the injectable version, which could force packaged food makers and fast-food chains to revamp products as more Americans opt for easy-to-swallow pills. Eli Lillys rival pill is expected to gain approval next year, expanding access even further. With around forty percent of American adults being obese and twelve percent already taking GLP-one drugs, the shift towards functional foods and targeted marketing is expected to reshape how we eat for the long haul.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.